EXPRESSION OF URINARY CHEMOKINES IN PATIENTS WITH OVERACTIVE BLADDER (OAB)

被引：1
|
作者：
Faruqui, Nuzhat
Ghoniem, Gamal
Mahdy, Ayman
Elmissiry, Mostafa
Mageed, Asim Abdel
机构：
来源：
JOURNAL OF UROLOGY | 2009年 / 181卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(09)61543-3
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1529
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [41] Psychometric evaluation of the Overactive Bladder Questionnaire (OAB-q) for measuring quality of life and clinical implications in Greek patients with overactive bladder
    Stavros Kontogiannis
    Anastasios Athanasopoulos
    Michail Tsagkarakis
    Nikolaos Kontodimopoulos
    International Urogynecology Journal, 2022, 33 : 3035 - 3043
  • [42] Efficacy of fesoterodine in patients with overactive bladder (OAB): Improvements in oab symptoms and health-related quality of life (HRQL)
    Chapple, Christopher
    Van Kerrebroeck, Philip
    Tubaro, Andrea
    Wang, Joseph T.
    Hvidsten, Kyle
    Brodsky, Marina
    JOURNAL OF UROLOGY, 2007, 177 (04): : 392 - 392
  • [43] Linguistic validation of the overactive bladder questionnaire (OAB-q), overactive bladder short form questionnaire (OAB-q SF), and OAB assessment tool (OAB-V8) in 4 languages
    Reilly, K.
    McKown, S.
    Gawlicki, M.
    Coyne, K. S.
    VALUE IN HEALTH, 2006, 9 (06) : A391 - A392
  • [44] Efficacy of fesoterodine in patients with overactive bladder (OAB): Improvements in OAB symptoms and health-related quality of life (HRQL)
    Chaoole, C.
    Van Kerrebroeck, P.
    Tubaro, A.
    Wang, J. T.
    Hvidsten, K.
    Brodsky, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 274 - 274
  • [45] A prospective study for out-patient onabotulinumtoxina treated patients with overactive bladder (OAB)
    Andersen, Karin
    Haahr, Martha
    Lund, Lars
    SCANDINAVIAN JOURNAL OF UROLOGY, 2017, 51 : 60 - 61
  • [46] Turkish Adaptation of Four Questionnaires for Patients with Overactive Bladder: The Overactive Bladder Questionnaire (OAB-q), Patient Perception of Bladder Condition (PPBC), Urgency Questionnaire (UQ), and the Primary OAB Symptom Questionnaire (POSQ)
    Aslan, E.
    Yalcin, O.
    Beji, N. Kizilkaya
    Ugurlucan, F. Gungor
    Erkan, H. Ayyildiz
    Ayvacikli, G.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2015, 26 : S66 - S67
  • [47] COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTS
    Arreola-Ornelas, H.
    Rosado-Buzzo, A.
    Garcia-Mollinedo, M.
    Camacho-Cordero, L.
    Mucino-Ortega, E.
    Mould-Quevedo, J. F.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2011, 14 (03) : A76 - A76
  • [48] Prevalence of cardiovascular co-morbidities in patients treated with antimuscarinics for overactive bladder (OAB)
    Andersson, K.
    Kahler, K.
    U, Ebinger
    NEUROUROLOGY AND URODYNAMICS, 2007, 26 (05) : 653 - 654
  • [49] Urinary Incontinence and Overactive Bladder in Patients With Heart Failure
    Palmer, Mary H.
    Hardin, Sonya R.
    Behrend, Carolyn
    Collins, Susan K. -R.
    Madigan, Catherine K.
    Carlson, John R.
    JOURNAL OF UROLOGY, 2009, 182 (01): : 196 - 202
  • [50] Real world outcomes of intravesical onabotulinum toxin a in patients with symptomatic overactive bladder (oab)
    Scrimgeour, Gemma
    Aleksejeva, Kristina
    Axell, Richard
    Yasmin, Habiba
    Nadeem, Mehwash
    Unterberg, Stephen
    Pakzad, Mahreen
    Hamid, Rizwan
    Ockrim, Jeremy
    Greenwell, Tamsin
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S210 - S211
12345